InvestorsHub Logo
Followers 30
Posts 6986
Boards Moderated 1
Alias Born 08/22/2008

Re: None

Thursday, 04/13/2017 8:41:32 PM

Thursday, April 13, 2017 8:41:32 PM

Post# of 24405
This is a quality major move today.....two new board members!!

Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers

On April 10, 2017, the Company received a letter of resignation dated April 9, 2017 from Gino Mauriello resigning as a Director. The remaining board member, Mr. De La Garza accepted the resignation.

On April 11, 2017, Mr. De La Garza as the only remaining board member appointed Albert Carlson PhD and Sammy E Davis DrPH to fill the two vacant board seats.

Albert Carlson, PhD, is 57 years of age and is the Company’s Chief Scientific Officer. He has extensive experience in on-time design to delivery while remaining under budget at all levels of engineering. Additionally, he has worked in many areas of engineering and has focused extensive world knowledge, as well as deep algorithmic, set theory, mathematical, and design expertise. Dr. Carlson holds a PhD in Computer Science from the University of Idaho.

Sammy E. Davis DrPH, 70 years of age has documented experience spanning over 20 years in operations, finance, budgeting, financial reporting, revenue cycle management, inventory, payroll, accounts receivable and payable, and information systems in the healthcare industry. He has held numerous managerial positions as a CEO and Administrator. Dr. Davis holds a Doctor of Public Health degree from the University of Texas.

There are no transactions involving the newly appointed Directors that are reportable under Item 404(a) of Regulation S-K for the purposes of this Current Report on Form 8-K.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SDCH News